Lee KW, Zang DY, Kim HD, Kim JW, et al. Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in
combination with paclitaxel in patients with biomarker-selected metastatic
gastric cancer. Br J Cancer 2025 May 21. doi: 10.1038/s41416-025-03052.
PMID: 40399487
![]() |
![]() |
![]() |